Union Budget 2026 industry reactions LIVE: FM Sitharaman Sets FY27 Fiscal Deficit Target At 4.3%, FY27 Capex At ₹12.2 Lakh Crore

3 months ago 1
ARTICLE AD BOX
A idiosyncratic    checks the density of alloy  bars wrong  a alloy  mill  connected  the outskirts of Ahmedabad, India, January 28, 2026.

A idiosyncratic checks the density of alloy bars wrong a alloy mill connected the outskirts of Ahmedabad, India, January 28, 2026. | Photo Credit: Reuters

Benchmark indices, Nifty 50 and Sensex 30 tanked station the Union Budget 2026-27 presented by Finance Minister Nirmala Sitharaman. 

Also Read | Union Budget 2026: From ‘Bahi Khata’ to ‘Blue Sheet’: Five absorbing things to know

Government suggest to enactment mineral affluent States of Odisha, Kerala, Andhra Pradesh and Tamil Nadu done dedicated corridors. Finance Minister besides projected to summation eletronics manufacturing ngo outlay to ₹40,000 crore.

Budget 2026: Odisha, T.N., Andhra, Kerala to get dedicated uncommon world corridors to beforehand probe and mining

The Economic Survey 2025-26 has painted a comparatively rosy representation of India’s home maturation outlook, raising the country’s medium-term outlook to 7% from its earlier estimation of 6.5%. However, it has simultaneously outlined a comparatively grim outlook for the planetary economy, estimating a 10-20% accidental of a situation worse than the planetary fiscal situation of 2008 unfolding successful 2026. Even its best-case script is simply a continuation of conditions arsenic they were successful 2025, but “increasingly little unafraid and much fragile”.

Follow the unrecorded updates

  • February 01, 2026 12:57

    Union Budget makes a decisive concern successful India’s wellness and innovation aboriginal by placing biopharma among frontier sectors: Biocon Chairperson

    “As India’s illness load shifts toward cancer, diabetes and autoimmune disorders, biologics and biosimilars volition beryllium cardinal to improving longevity and prime of life. This initiative—spanning manufacturing scale-up, global-grade regulation, caller NIPER institutions and a nationwide objective trials network—can firmly presumption India arsenic a planetary biopharma manufacturing hub.” 

    -Kiran Mazumdar Shaw, Chairperson , Biocon Group

Published - February 01, 2026 12:58 p.m. IST

Read Entire Article